A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma

BACKGROUND/AIM: A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Health auth...

Descripción completa

Detalles Bibliográficos
Autores principales: GEMİCİ, Aliihsan, BİLGEN, Hülya, ERDOĞAN, Cem, KANSU, Abdullah, OLMUŞÇELİK, Oktay, BEKÖZ, Hüseyin Saffet, DİNLEYİCİ, Rümeysa, MERT, Ali, SEVİNDİK, Ömür Gökmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775681/
https://www.ncbi.nlm.nih.gov/pubmed/33078604
http://dx.doi.org/10.3906/sag-2009-77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7775681/
https://www.ncbi.nlm.nih.gov/pubmed/33078604
http://dx.doi.org/10.3906/sag-2009-77

Ejemplares similares